All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
L-MIND study, MOR208 + lenalidomide in R/R DLBCL
New chemotherapy-free approaches for the treatment of lymphoid malignancies
At the 15th International Conference on Malignant Lymphoma, the Lymphoma Hub Satellite Symposium highlighted recent advances in chemotherapy-free options in the field of...
Lenalidomide combined with tafasitamab in relapsed/refractory diffuse large B-cell lymphoma
In a study published in The Lancet Oncology, our Lymphoma Hub Chair, Gilles Salles, and colleagues investigated whether lenalidomide could be used...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox